Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Diagnostics (Basel, Switzerland)|October 23, 2021
Single-Breath-Hold MRI-SPACE Cholangiopancreatography with Compressed Sensing versus Conventional Respiratory-Triggered MRI-SPACE Cholangiopancreatography at 3Tesla: Comparison of Image Quality and Diagnostic ConfidenceOlivier Chevallier, Hélène Escande, Khalid Ambarki, et al.
Cancers|April 12, 2022
Management and Outcomes of Pancreatic Cancer in French Real-World Clinical PracticeValérie Jooste, Leila Bengrine-Lefevre, Sylvain Manfredi, et al.
Chemotherapy|May 11, 2012
Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four yearsMarc Pracht, Guillaume Le Roux, Laurent Sulpice, et al.
Targeted Oncology|November 2, 2017
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO StudyAziz Zaanan, Juliette Palle, Emilie Soularue, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2018
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III studyJean-Marc Phelip, Julien Edeline, Jean-Frédéric Blanc, et al.
Cancers|September 28, 2023
Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB TrialJustine Paris, Pauline Legris, Madeline Devaux, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 1, 2012
Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programmeJean Faivre, Vincent Dancourt, Sylvain Manfredi, et al.
BMC Cancer|January 5, 2023
Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD)Lydia Guittet, Valérie Quipourt, Thomas Aparicio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 22, 2025
What are the outcomes for long-term survivors after esophagectomy ? - Evidence from a randomized controlled trial (FFCD9901)William B Robb, Julie Veziant, Laetitia Dahan, et al.
Cancers|January 8, 2023
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon CancerBenjamin Tournier, Romain Aucagne, Caroline Truntzer, et al.
Pageof 11